Articles

An Expanded Role for Precision Medicine
Peter Tun, Manager, Magnolia Innovation, says that he wants to see every patient get the care they need without cost barriers. This would include using precision medicine to deliver the best care possible at the lowest cost.
Read More

Optimizing Precision Medicine
As we learn more about precision medicine and how to identify biomarkers, Peter Tun, Manager, Magnolia Innovation, would like to see more discussion among stakeholders on how to optimize these findings in future gatherings.
Read More

AVBCC Delivers a Brillliant Opportunity
The AVBCC Summit is a great opportunity to hear from different stakeholders and meet some very brilliant people, said Peter Tun, Manager, Magnolia Innovation. And, it offers the chance to focus on the changing oncology landscape.
Read More

Uncommon Breadth of Thought Leaders at AVBCC Summit
Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, says that few conferences have the breadth of thought leaders who are present at AVBCC with the opportunity to move cancer care forward.
Read More

Regaining Momentum
"We have done a lot of good work--but we still have a lot of work to do," said Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health. He added, "we need to regain momentum" that was stalled during the pandemic.
Read More

Sharing Insights for Mutual Benefit
Sharing Insights for mutual benefit is what Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, says is a key factor in attending AVBCC Summit.
Read More

Focus on a Vision for the Future
Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, wants to put the individual patient at the center of cancer care, and this requires stakeholders to focus on this goal together, he said.
Read More

An Agenda for Next Steps
Value-based pharmaceutical design, government plans for CMS, and discussion of incentivizing high-value, low-cost care, are a few of the things to prioritize for future meetings, said Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health.
Read More

Facilitating Progress and Innovation at AVBCC Summit
Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, says his colleagues should attend AVBCC because it is a great place to come together to facilitate the process of innovation.
Read More

Avapritinib was recently approved for treatment in advanced systemic mastocytosis after demonstrating in clinicals trials the ability to improve hematologic and bone marrow responses in patients.
Read More

Page 32 of 329